<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cholesterol metabolism is believed to play a role in the development of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="53030">Oxysterol</z:chebi> metabolites of cholesterol, <z:chebi fb="0" ids="34310">24S-hydroxycholesterol</z:chebi> (24-OHC, a brain-derived <z:chebi fb="0" ids="53030">oxysterol</z:chebi>) and 27-hydroxycholesterol (27-OHC, a peripherally derived <z:chebi fb="0" ids="53030">oxysterol</z:chebi>) cross the blood brain barrier and have been associated with AD </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated whether <z:chebi fb="0" ids="53030">oxysterols</z:chebi> were associated with markers of cerebrovascular disease prior to the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="53030">Oxysterols</z:chebi> were quantified in 105 participants (average age: 80 Â± 4 years) from the Pittsburgh Cardiovascular Health Study Cognition Study who remained cognitively <z:mpath ids='MPATH_458'>normal</z:mpath> at blood draw in 2002, had MRI in 1992 and 1998, and annual cognitive assessment for incident AD and mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> made by consensus conference between 1998 and 2010 </plain></SENT>
<SENT sid="4" pm="."><plain>Higher plasma levels of 24-OHC were associated with age, gender, the presence of high grade white matter hyperintensities, and brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> on prior MRI </plain></SENT>
<SENT sid="5" pm="."><plain>Participants with higher plasma 24-OHC and a greater ratio of 24-OHC/27-OHC were also more likely to develop incident <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> over 8 years of follow-up </plain></SENT>
<SENT sid="6" pm="."><plain>Higher levels of 24-OHC suggest increased cholesterol metabolism occurring in the brains of participants with cerebrovascular disease prior to the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Measurement of <z:chebi fb="0" ids="53030">oxysterols</z:chebi> may provide information about cholesterol metabolism and <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e> over the <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> process </plain></SENT>
</text></document>